A Phase II Trial of PD-1 Knockout Engineered T Cells for the Treatment of Advanced Lung Squamous Carcinoma progressed after multi-line treatment
Latest Information Update: 13 Jan 2017
At a glance
- Drugs PD-1 knockout T-cells (Primary)
- Indications Carcinoma; Lung cancer
- Focus Adverse reactions
- 13 Jan 2017 New trial record